UBERON:0001473

Name:	lymphatic vessel
Definition:	"A vessel that contains or conveys lymph, that originates as an interfibrillar or intercellular cleft or space in a tissue or organ, and that if small has no distinct walls or walls composed only of endothelial cells and if large resembles a vein in structure[BTO]." [BTO:0000752, Wikipedia:Lymphatic_vessel]
Xrefs:	Expandlinks: AAO:0011005 BTO:0000752 EFO:0000873 FMA:30315 [1] MA:0000138 MAT:0000443 ncithesaurus:Lymphatic_Vessel OpenCyc:Mx4rwA1fYZwpEbGdrcN5Y29ycA SCTID:279089004 TAO:0005105 VHOG:0001249 XAO:0000375
Synonyms:	"lymph vessel" EXACT []
Alt_id:	UBERON:FMA_30315-FMA_5034-MA_0000138-MA_0000139-MIAA_0000197-XAO_0000375-ZFA_0005105
Subset:	uberon_slim vertebrate_core

Ontology association<br>Each term has an is_a parent in the Uberon Ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to UBERON ontologies.<br><br>link to ontology dataset<br>data

---

Parents

is_a:	UBERON:0000055(vessel)
disjoint_from:	UBERON:0001981(blood vessel)
part_of:	UBERON:0004536(lymph vasculature),UBERON:0006558(lymphatic part of lymphoid system)

Children

part of:	CL:0002138 (endothelial cell of lymphatic vessel),CL:0002554 (fibroblast of lymphatic vessel)

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)

FF samples<br>It includes FANTOM5 samples that overlay the Uberon ontology

---

Human (Homo sapiens)

• 11236-116D3 (Endothelial Cells - Lymphatic, donor1)
• 11317-117D3 (Endothelial Cells - Lymphatic, donor2)
• 11393-118C7 (Endothelial Cells - Lymphatic, donor3)
• 11506-119G3 (Fibroblast - Lymphatic, donor1)
• 11586-120G2 (Fibroblast - Lymphatic, donor2)
• 11638-122C9
• 11667-122G2 (Fibroblast - Lymphatic, donor3)
• 11715-123C5
• 11733-123E5
• 12260-130A1 (Lymphatic Endothelial cells response to VEGFC)

... further results

Enrichment analysis: top 100 FFCP enriched with this ontology term TOP 100 FANTOM5 Cage Peaks enriched with UBERON:0001473 (lymphatic vessel), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data

---

Copy Excel CSV PDF

Search:

P-value	FFCP	Short description

P-value	FFCP	Short description
5.05e-102	FFCP PHASE2:Hg19::chr9:13432964..13432971,-	p@chr9:13432964..13432971, -
5.05e-102	FFCP PHASE1:Hg19::chr9:13432964..13432971,-	p@chr9:13432964..13432971, -
4.74e-79	FFCP PHASE1:Hg19::chr1:65344872..65344880,-	p15@JAK1
4.74e-79	FFCP PHASE2:Hg19::chr1:65344872..65344880,-	p15@JAK1
1.08e-76	FFCP PHASE1:Hg19::chr3:30560368..30560379,+	p@chr3:30560368..30560379, +
1.08e-76	FFCP PHASE2:Hg19::chr3:30560368..30560379,+	p@chr3:30560368..30560379, +
6.73e-74	FFCP PHASE2:Hg19::chr17:28534912..28534942,-	p@chr17:28534912..28534942, -
6.73e-74	FFCP PHASE1:Hg19::chr17:28534912..28534942,-	p@chr17:28534912..28534942, -
2.1e-68	FFCP PHASE1:Hg19::chr2:56149881..56149899,-	p14@EFEMP1
2.1e-68	FFCP PHASE2:Hg19::chr2:56149881..56149899,-	p14@EFEMP1
1.18e-65	FFCP PHASE1:Hg19::chr19:48613876..48613886,-	p7@PLA2G4C
1.18e-65	FFCP PHASE2:Hg19::chr19:48613876..48613886,-	p7@PLA2G4C
3.64e-64	FFCP PHASE1:Hg19::chr6:74848034..74848043,+	p@chr6:74848034..74848043, +
3.64e-64	FFCP PHASE2:Hg19::chr6:74848034..74848043,+	p@chr6:74848034..74848043, +
6.87e-57	FFCP PHASE1:Hg19::chr6:5054373..5054392,-	p1@AK126470
6.87e-57	FFCP PHASE2:Hg19::chr6:5054373..5054392,-	p1@AK126470
9.15e-57	FFCP PHASE1:Hg19::chr7:79998842..79998855,+	p25@CD36
9.15e-57	FFCP PHASE2:Hg19::chr7:79998842..79998855,+	p25@CD36
1.06e-56	FFCP PHASE1:Hg19::chr3:145968441..145968451,-	p17@PLSCR4
1.06e-56	FFCP PHASE2:Hg19::chr3:145968441..145968451,-	p17@PLSCR4
1.22e-56	FFCP PHASE1:Hg19::chr2:33661536..33661549,+	p17@RASGRP3
1.22e-56	FFCP PHASE2:Hg19::chr2:33661536..33661549,+	p17@RASGRP3
1.41e-56	FFCP PHASE1:Hg19::chr9:13446440..13446456,+	p2@ENST00000428006
1.41e-56	FFCP PHASE2:Hg19::chr9:13446440..13446456,+	p2@ENST00000428006
4.57e-56	FFCP PHASE1:Hg19::chr12:46807404..46807413,+	p@chr12:46807404..46807413, +
4.57e-56	FFCP PHASE2:Hg19::chr17:28534879..28534889,-	p@chr17:28534879..28534889, -
4.57e-56	FFCP PHASE2:Hg19::chr12:46807404..46807413,+	p@chr12:46807404..46807413, +
4.57e-56	FFCP PHASE1:Hg19::chr17:28534879..28534889,-	p@chr17:28534879..28534889, -
6.66e-56	FFCP PHASE1:Hg19::chr7:79998905..79998917,+	p26@CD36
6.66e-56	FFCP PHASE2:Hg19::chr7:79998905..79998917,+	p26@CD36
2.32e-54	FFCP PHASE2:Hg19::chr8:30300216..30300245,+	p10@RBPMS
2.32e-54	FFCP PHASE1:Hg19::chr8:30300216..30300245,+	p10@RBPMS
3.99e-50	FFCP PHASE2:Hg19::chr4:114238344..114238353,+	p58@ANK2
3.99e-50	FFCP PHASE1:Hg19::chr11:108794408..108794422,+	p@chr11:108794408..108794422, +
3.99e-50	FFCP PHASE1:Hg19::chr4:114238344..114238353,+	p58@ANK2
3.99e-50	FFCP PHASE1:Hg19::chr1:66723029..66723041,+	p54@PDE4B
3.99e-50	FFCP PHASE2:Hg19::chr1:66723029..66723041,+	p54@PDE4B
3.99e-50	FFCP PHASE1:Hg19::chr2:33661526..33661535,+	p23@RASGRP3
3.99e-50	FFCP PHASE2:Hg19::chr2:33661526..33661535,+	p23@RASGRP3
3.99e-50	FFCP PHASE1:Hg19::chr11:108794429..108794441,+	p@chr11:108794429..108794441, +
3.99e-50	FFCP PHASE2:Hg19::chr11:108794408..108794422,+	p@chr11:108794408..108794422, +
3.99e-50	FFCP PHASE2:Hg19::chr11:108794429..108794441,+	p@chr11:108794429..108794441, +
3.99e-50	FFCP PHASE1:Hg19::chr17:75873825..75873826,+	p@chr17:75873825..75873826, +
3.99e-50	FFCP PHASE2:Hg19::chr17:75873825..75873826,+	p@chr17:75873825..75873826, +
9.58e-48	FFCP PHASE1:Hg19::chr4:189881560..189881604,-	p@chr4:189881560..189881604, -
9.58e-48	FFCP PHASE2:Hg19::chr4:189881560..189881604,-	p@chr4:189881560..189881604, -
1.55e-47	FFCP PHASE1:Hg19::chr4:90857427..90857438,+	p@chr4:90857427..90857438, +
1.55e-47	FFCP PHASE2:Hg19::chr4:90857427..90857438,+	p@chr4:90857427..90857438, +
1.71e-47	FFCP PHASE1:Hg19::chr10:4823152..4823165,-	p@chr10:4823152..4823165, -
1.71e-47	FFCP PHASE2:Hg19::chr10:4823152..4823165,-	p@chr10:4823152..4823165, -
3.05e-47	FFCP PHASE1:Hg19::chr6:49534004..49534016,+	p@chr6:49534004..49534016, +
3.05e-47	FFCP PHASE2:Hg19::chr6:49534004..49534016,+	p@chr6:49534004..49534016, +
7.08e-47	FFCP PHASE1:Hg19::chr12:96841308..96841312,+	p@chr12:96841308..96841312, +
7.08e-47	FFCP PHASE2:Hg19::chr12:96841308..96841312,+	p@chr12:96841308..96841312, +
3.73e-45	FFCP PHASE1:Hg19::chr1:43917566..43917577,-	p6@HYI
3.73e-45	FFCP PHASE2:Hg19::chr1:43917566..43917577,-	p6@HYI
4.34e-45	FFCP PHASE1:Hg19::chr3:34262215..34262222,+	p@chr3:34262215..34262222, +
4.34e-45	FFCP PHASE2:Hg19::chr3:34262215..34262222,+	p@chr3:34262215..34262222, +
5.04e-45	FFCP PHASE1:Hg19::chr18:54339814..54339822,+	p7@WDR7
5.04e-45	FFCP PHASE2:Hg19::chr18:54339814..54339822,+	p7@WDR7
6.81e-45	FFCP PHASE1:Hg19::chr7:10196589..10196595,-	p@chr7:10196589..10196595, -
6.81e-45	FFCP PHASE2:Hg19::chr7:10196589..10196595,-	p@chr7:10196589..10196595, -
7.92e-45	FFCP PHASE1:Hg19::chr2:62705562..62705579,+	p@chr2:62705562..62705579, +
7.92e-45	FFCP PHASE2:Hg19::chr2:62705562..62705579,+	p@chr2:62705562..62705579, +
3.69e-44	FFCP PHASE1:Hg19::chr4:90856951..90856962,+	p@chr4:90856951..90856962, +
3.69e-44	FFCP PHASE2:Hg19::chr4:90856951..90856962,+	p@chr4:90856951..90856962, +
3.69e-44	FFCP PHASE1:Hg19::chr12:71031281..71031292,-	p12@PTPRB
3.69e-44	FFCP PHASE2:Hg19::chr12:71031281..71031292,-	p12@PTPRB
3.18e-40	FFCP PHASE1:Hg19::chr12:105882068..105882076,+	p@chr12:105882068..105882076, +
3.18e-40	FFCP PHASE2:Hg19::chr12:105882068..105882076,+	p@chr12:105882068..105882076, +
3.89e-40	FFCP PHASE1:Hg19::chr8:6459787..6459796,+	p@chr8:6459787..6459796, +
3.89e-40	FFCP PHASE2:Hg19::chr8:6459787..6459796,+	p@chr8:6459787..6459796, +
1.55e-39	FFCP PHASE1:Hg19::chr4:38057595..38057624,-	p@chr4:38057595..38057624, -
1.55e-39	FFCP PHASE2:Hg19::chr4:38057595..38057624,-	p@chr4:38057595..38057624, -
6.2e-39	FFCP PHASE1:Hg19::chr3:194868639..194868654,+	p1@ENST00000426468
6.2e-39	FFCP PHASE2:Hg19::chr3:194868639..194868654,+	p1@ENST00000426468
9.18e-38	FFCP PHASE1:Hg19::chr8:16425014..16425019,-	p13@MSR1
9.18e-38	FFCP PHASE2:Hg19::chr8:16425014..16425019,-	p13@MSR1
1.51e-37	FFCP PHASE1:Hg19::chr6:168195978..168195989,+	p3@LOC441179
1.51e-37	FFCP PHASE2:Hg19::chr6:168195978..168195989,+	p3@LOC441179
1.95e-37	FFCP PHASE1:Hg19::chr2:27487913..27487933,-	p@chr2:27487913..27487933, -
1.95e-37	FFCP PHASE2:Hg19::chr2:27487913..27487933,-	p@chr2:27487913..27487933, -
5.85e-37	FFCP PHASE1:Hg19::chr8:6420777..6420779,-	p5@ANGPT2
5.85e-37	FFCP PHASE2:Hg19::chr8:6420777..6420779,-	p5@ANGPT2
1.23e-36	FFCP PHASE1:Hg19::chr6:168195926..168195943,+	p1@LOC441179
1.23e-36	FFCP PHASE2:Hg19::chr6:168195926..168195943,+	p1@LOC441179
1.33e-36	FFCP PHASE1:Hg19::chr10:94590895..94590905,+	p8@EXOC6
1.33e-36	FFCP PHASE2:Hg19::chr10:94590895..94590905,+	p8@EXOC6
5.59e-36	FFCP PHASE2:Hg19::chr8:16425043..16425061,-	p5@MSR1
5.59e-36	FFCP PHASE1:Hg19::chr8:16425043..16425061,-	p5@MSR1
1.86e-34	FFCP PHASE1:Hg19::chr17:79426425..79426444,+	p@chr17:79426425..79426444, +
1.86e-34	FFCP PHASE2:Hg19::chr17:79426425..79426444,+	p@chr17:79426425..79426444, +
3.14e-34	FFCP PHASE1:Hg19::chr11:57543275..57543296,+	p@chr11:57543275..57543296, +
3.14e-34	FFCP PHASE2:Hg19::chr11:57543275..57543296,+	p@chr11:57543275..57543296, +
2.31e-33	FFCP PHASE1:Hg19::chr19:45226133..45226157,-	p@chr19:45226133..45226157, -
2.31e-33	FFCP PHASE2:Hg19::chr19:45226133..45226157,-	p@chr19:45226133..45226157, -
2.61e-33	FFCP PHASE1:Hg19::chr3:159570877..159570888,+	p43@SCHIP1
2.61e-33	FFCP PHASE2:Hg19::chr3:159570877..159570888,+	p43@SCHIP1
7.63e-33	FFCP PHASE1:Hg19::chr12:71031220..71031229,-	p10@PTPRB
7.63e-33	FFCP PHASE2:Hg19::chr12:71031220..71031229,-	p10@PTPRB

Showing 1 to 100 of 100 entries